1.5T LINX, 14B LXMC14

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2020-03-06 for 1.5T LINX, 14B LXMC14 manufactured by Torax Medical, Inc..

Event Text Entries

[185659822] (b)(4). Date sent: (b)(6) 2020. Date of event: only event year known: 2020. Additional information received: confirmed with the coordinator that this is not a discontinuous device but was part of the recall. Esophagram done before explant not cxr. Positive ph bravo study post implant on (b)(6) 2017. Had egd done (b)(6) 2019 and (b)(6) 2020. Device is lxmc-14. Lot 9408 and serial # (b)(4). Removal date (b)(6) 2020. Implanting surgeon dr. (b)(6). Explanting surgeon dr. (b)(6). Date of onset of symptoms (b)(6) 2016 some difficulty swallowing from time to time especially with breads. Or too much water. 6-2019 ct done for abdominal pain and continued difficulty swallowing was the device replaced or a fundoplication done or a dor fundoplication was done same day as removal. Any mris done since the device was implanted back in 2016? Yes one of the brain (b)(6) 2019 but it was with the 1. 5 tesla as that is what his was permitted how? S the patient doing now? Was kept npo for 12 hours after removal, esophogram was done the following day. We have talked to him once since. He is doing as expected. Attempts are being made to obtain the following information. To date no response has been provided. If further details are received at a later date a supplemental medwatch will be sent. Prior to linx placement, did the patient have an egd, ph, and manometry studies done? If yes, could you please share the results? When using the linx sizing device what technique was used to determine the size? Did the patient have an autoimmune disease? Is the patient currently taking steroids / immunization drugs? Did the patient have any pre-existing dysphagia or other conditions (other than gerd)? How severe was the dysphagia/odynophagia before intervention? Were there any intra-operative complications during implant? Was there any hiatal or crural repair done at the same time as the implant? Were there any other contributing factors that led to the removal of the device other than the reported dysphagia and abdominal pain? Was the device found in the correct position/geometry at the time of removal? (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[185659823] It was reported that a linx device was recently removed and she understood it was part of the recall. Implant date of (b)(6) 2016.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3008766073-2020-00040
MDR Report Key9799431
Report SourceCOMPANY REPRESENTATIVE
Date Received2020-03-06
Date of Report2020-02-11
Date Mfgr Received2020-03-09
Device Manufacturer Date2015-10-27
Date Added to Maude2020-03-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactKARA DITTY-BOVARD
Manufacturer Street4188 LEXINGTON AVENUE NORTH
Manufacturer CitySHOREVIEW MN
Manufacturer Phone6107428552
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand Name1.5T LINX, 14B
Generic NameANTI-REFLUX IMPLANT
Product CodeLEI
Date Received2020-03-06
Returned To Mfg2020-03-05
Model NumberLXMC14
Catalog NumberLXMC14
Lot Number9408
Device Expiration Date2019-10-27
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerTORAX MEDICAL, INC.
Manufacturer Address4188 LEXINGTON AVENUE NORTH SHOREVIEW MN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.